The ChEMBL-og

APRIL 16, 2024

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g. FDA. This data is currently available for European Medicines Agency drugs only.

Clinical Trials 110

Clinical Trials FDA Cell Based Assays Packaging 110

The Pharma Data

JANUARY 6, 2021

Next-generation digital technologies are having an immense impact on the drug discovery process. The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab.

Cell Based Assays 52

Cell Based Assays Compound Screening Organic Chemistry DNA 52

Drug Discovery World

AUGUST 15, 2023

Can potentially lethal arrhythmias induced by novel drugs be better predicted by using more relevant and sophisticated electrophysiological screening methods? Such techniques, if routinely deployed in drug discovery, may enable improved decision making in predicting serious adverse cardiovascular events.

Drugs 130

Drugs Clinical Pharmacology Disease Engineering 130